Investigational Cream Promising for Atopic Dermatitis

MONDAY, Jan. 14, 2019 -- Topical application of a transient receptor potential vanilloid subfamily, member 1 (TRPV1) antagonist may be an effective and safe treatment for patients with mild-to-moderate atopic dermatitis (AD), according to a phase...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news